A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression

The standard chemotherapies for neuroendocrine tumors (NETs) are somatostatin analog (SSA) and targeted-agents for NET G1/G2 and platinum-based chemotherapy for neuroendocrine carcinoma (NEC), classified according to the WHO criteria of 2010. We report a case of NET, in which tumors were successfull...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamano, Yukako, Moriwaki, Toshikazu, To, Keii, Watahiki, Takahisa, Yamada, Takeshi, Sakashita, Shingo, Hyodo, Ichinosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522411/
https://www.ncbi.nlm.nih.gov/pubmed/30568142
http://dx.doi.org/10.2169/internalmedicine.1809-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522411/
https://www.ncbi.nlm.nih.gov/pubmed/30568142
http://dx.doi.org/10.2169/internalmedicine.1809-18

Ejemplares similares